CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes [Phase 3]
Summary
A Phase 3 trial comparing insulin degludec to insulin detemir, each in combination with insulin aspart, in pregnant women with type 1 diabetes has completed, wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2022-04-27